NxStage sent a letter dated March 18, 2013, via email to all consignees instructing them to check their entire inventory and to segregate and quarantine lot F023444 pending further instruction from NxStage.
On 4/2/13 NxStage sent a letter via email to all consignees requesting a return of all RFP-400 and RFP-401 labeled with lot F023444.. Consignees were instructed to complete the recall reply form and provide a list of customers (name address, phone number) and fax them to NXStage Medical, Inc.
Customers with questions were instructed to call 1-866-697-8243.
For questions regarding this recall call 1-866-697-8243.
Initiated
2013-03-18
Root cause
Labeling mix-ups
Terminated
2014-09-17
Distribution
Nationwide Distribution including IL, SC, TX, VA, FL, AR, and NY.
Recall number
Z-1214-2013
Recall status
Terminated
CDRH record ID
117126
FDA classified
2013-05-02
Recall event number
64820
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.